Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Cristofoletti

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Journal of Personalized Medicine|November 26, 2025
Physiologically Based Pharmacokinetic Modeling of Clobazam and Stiripentol Co-Therapy in Dravet SyndromeBassma Eltanameli, Sulafa Al Sahlawi, Rodrigo Cristofoletti
Frontiers in Pharmacology|October 7, 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of <i>in-vivo</i> CRISPR-Cas therapyDevam A Desai, Stephan Schmidt, Rodrigo Cristofoletti
Expert Opinion on Drug Metabolism & Toxicology|June 8, 2024
Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriersBassma Eltanameli, Janny Piñeiro-Llanes, Rodrigo Cristofoletti
Frontiers in Pharmacology|May 25, 2023
Editorial: Insights in drug metabolism and transport: 2021Janny Piñeiro-Llanes, David E Stec, Rodrigo Cristofoletti
The Journal of Pharmacy and Pharmacology|April 2, 2015
Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric populationNaseem A Charoo, Rodrigo Cristofoletti, Jennifer B Dressman
Drug Development and Industrial Pharmacy|December 30, 2016
Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approachNaseem A Charoo, Rodrigo Cristofoletti, Sun K Kim
The AAPS Journal|November 23, 2021
Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?Yesenia L Franco, Lais Da Silva, Rodrigo Cristofoletti
Journal of Pharmaceutical Sciences|March 19, 2016
Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption ModelRodrigo Cristofoletti, Naseem A Charoo, Jennifer B Dressman
British Journal of Clinical Pharmacology|April 27, 2020
Assessing the impact of cystic fibrosis on the antipyretic response of ibuprofen in children: Physiologically-based modeling as a candle in the darkBrian Cicali, Tao Long, Sarah Kim, et al.
Developmental Cell|November 18, 2025
Epithelial-derived basement membranes help orchestrate crypt-villus patterning in vitroJanny Pineiro-Llanes, Mashael F Aldossari, Rodrigo Cristofoletti
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Journal of Personalized Medicine|November 26, 2025
Physiologically Based Pharmacokinetic Modeling of Clobazam and Stiripentol Co-Therapy in Dravet SyndromeBassma Eltanameli, Sulafa Al Sahlawi, Rodrigo Cristofoletti
Frontiers in Pharmacology|October 7, 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of <i>in-vivo</i> CRISPR-Cas therapyDevam A Desai, Stephan Schmidt, Rodrigo Cristofoletti
Expert Opinion on Drug Metabolism & Toxicology|June 8, 2024
Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriersBassma Eltanameli, Janny Piñeiro-Llanes, Rodrigo Cristofoletti
Frontiers in Pharmacology|May 25, 2023
Editorial: Insights in drug metabolism and transport: 2021Janny Piñeiro-Llanes, David E Stec, Rodrigo Cristofoletti
The Journal of Pharmacy and Pharmacology|April 2, 2015
Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric populationNaseem A Charoo, Rodrigo Cristofoletti, Jennifer B Dressman
Drug Development and Industrial Pharmacy|December 30, 2016
Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approachNaseem A Charoo, Rodrigo Cristofoletti, Sun K Kim
The AAPS Journal|November 23, 2021
Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?Yesenia L Franco, Lais Da Silva, Rodrigo Cristofoletti
Journal of Pharmaceutical Sciences|March 19, 2016
Exploratory Investigation of the Limiting Steps of Oral Absorption of Fluconazole and Ketoconazole in Children Using an In Silico Pediatric Absorption ModelRodrigo Cristofoletti, Naseem A Charoo, Jennifer B Dressman
British Journal of Clinical Pharmacology|April 27, 2020
Assessing the impact of cystic fibrosis on the antipyretic response of ibuprofen in children: Physiologically-based modeling as a candle in the darkBrian Cicali, Tao Long, Sarah Kim, et al.
Developmental Cell|November 18, 2025
Epithelial-derived basement membranes help orchestrate crypt-villus patterning in vitroJanny Pineiro-Llanes, Mashael F Aldossari, Rodrigo Cristofoletti
Pageof 11